ShareResearchers at Leiden University Medical Center and Radboud University Medical Center in the Netherlands have demonstrated promising safety and efficacy of a late-liverstage attenuated malaria parasite vaccine in a clinical trial. The study is published in the ‘New England Journal of Medicine’. The researchers found that immunisation with a genetically modified Plasmodium falciparum parasite, known...

The post New Malaria Vaccine Shows High Protection In Trial– Study appeared first on New Telegraph.